ENTX: Entera Bio Ltd. Stocks News on July 6, 2025

OPKO Health (OPK) to Present OPK-88006 Data at ENDO 2025

ENTX

Insider Monkey

7 days ago

OPKO Health (OPK) to Present OPK-88006 Data at ENDO 2025

Entera Bio Data for EB613 Effects on Trabecular and Cortical Bone in Post-Menopausal Women with Osteoporosis Selected for Oral Presentation at ASBMR 2025 Annual Meeting

ENTX

GlobeNewswire

10 days ago

Entera Bio Data for EB613 Effects on Trabecular and Cortical Bone in Post-Menopausal Women with Osteoporosis Selected for Oral Presentation at ASBMR 2025 Annual Meeting

OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting

ENTX

GlobeNewswire

11 days ago

OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting

ENTX

GlobeNewswire

11 days ago

OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting

Piper Sandler Reiterates a Buy Rating on Opko Health (OPK) With a $3 PT

ENTX

Insider Monkey

12 days ago

Piper Sandler Reiterates a Buy Rating on Opko Health (OPK) With a $3 PT

ENTX

MT Newswires

a month ago

Entera Bio Files $100 Million Mixed Shelf

Entera Bio Announces First Quarter 2025 Financial Results and Business Updates

ENTX

GlobeNewswire

2 months ago

Entera Bio Announces First Quarter 2025 Financial Results and Business Updates

Entera Bio’s EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis - Highlighted as Oral Presentation at WCO-IOF ESCEO

ENTX

GlobeNewswire

3 months ago

Entera Bio’s EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis - Highlighted as Oral Presentation at WCO-IOF ESCEO

Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates

ENTX

GlobeNewswire

3 months ago

Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates

Opko and Entera focus on oral care for obesity and metabolic disorders

ENTX

Pharmaceutical Technology

4 months ago

Opko and Entera focus on oral care for obesity and metabolic disorders

ENTX

MT Newswires

4 months ago

OPKO, Entera to Co-Develop Oral GLP-1/Glucagon Therapy for Obesity

OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders

ENTX

GlobeNewswire

4 months ago

OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders

Entera Bio to Participate in Upcoming Events

ENTX

GlobeNewswire

4 months ago

Entera Bio to Participate in Upcoming Events

EFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND CORTICAL BONE USING 3D-DXA: POST-HOC RESULTS FROM PHASE 2 STUDY Accepted for Oral Presentation at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

ENTX

GlobeNewswire

5 months ago

EFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND CORTICAL BONE USING 3D-DXA: POST-HOC RESULTS FROM PHASE 2 STUDY Accepted for Oral Presentation at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

US Penny Stocks: 3 Picks With Market Caps Over $60M

ENTX

Simply Wall St.

5 months ago

US Penny Stocks: 3 Picks With Market Caps Over $60M

ENTX

Simply Wall St.

5 months ago

Is Entera Bio (NASDAQ:ENTX) In A Good Position To Deliver On Growth Plans?

Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

ENTX

GlobeNewswire

5 months ago

Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

ENTX

Zacks

8 months ago

Entera Bio Ltd. (ENTX) Reports Q3 Loss, Tops Revenue Estimates

Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates

ENTX

GlobeNewswire

8 months ago

Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates

Are Medical Stocks Lagging Argenx (ARGX) This Year?

ENTX

Zacks

9 months ago

Are Medical Stocks Lagging Argenx (ARGX) This Year?

ENTX

Zacks

9 months ago

ENTX & OPK Stock May Gain Following Positive PK/PD Research Data

Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders

ENTX

GlobeNewswire

9 months ago

Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders

ENTX

Zacks

10 months ago

Is Entera Bio (ENTX) Stock Outpacing Its Medical Peers This Year?

ENTX

Zacks

10 months ago

Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year?

ENTX

Simply Wall St.

10 months ago

We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate

Entera Bio to Participate in Upcoming Investor and Scientific Conferences

ENTX

GlobeNewswire

a year ago

Entera Bio to Participate in Upcoming Investor and Scientific Conferences

ENTX

Zacks

a year ago

All You Need to Know About Entera Bio (ENTX) Rating Upgrade to Buy

Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates

ENTX

GlobeNewswire

a year ago

Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates

Entera’s EB613, the First Once Daily PTH(1-34) Tablet Treatment Dedicated to Post-Menopausal Women with High Risk Osteoporosis Abstract Selected for Presentation at the ASBMR 2024 Annual Meeting - Key SABRE Update Also Expected

ENTX

GlobeNewswire

a year ago

Entera’s EB613, the First Once Daily PTH(1-34) Tablet Treatment Dedicated to Post-Menopausal Women with High Risk Osteoporosis Abstract Selected for Presentation at the ASBMR 2024 Annual Meeting - Key SABRE Update Also Expected

Italian energy company targets Britain for fleet of 20 mini-nukes

ENTX

The Telegraph

a year ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

ENTX

Motley Fool

a year ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

ENTX

AFP

a year ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

ENTX

Simply Wall St.

a year ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

ENTX

Simply Wall St.

a year ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

ENTX

Simply Wall St.

a year ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

ENTX

Simply Wall St.

a year ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

ENTX

Motley Fool

a year ago

3 Mistakes That Can Get Your Costco Membership Canceled

ENTX

Zacks

a year ago

Has Entera Bio (ENTX) Outpaced Other Medical Stocks This Year?

Entera Bio Reports Phase 1 Clinical Data of First-in-Class, Oral PTH(1-34) Peptide Candidate (EB612) for Patients with Hypoparathyroidism at ENDO 2024

ENTX

GlobeNewswire

a year ago

Entera Bio Reports Phase 1 Clinical Data of First-in-Class, Oral PTH(1-34) Peptide Candidate (EB612) for Patients with Hypoparathyroidism at ENDO 2024

Vanda (VNDA) Rises on Positive Data From Motion Sickness Study

ENTX

Zacks

a year ago

Vanda (VNDA) Rises on Positive Data From Motion Sickness Study

ENTX

Zacks

a year ago

Are Medical Stocks Lagging Entera Bio (ENTX) This Year?

Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member

ENTX

GlobeNewswire

a year ago

Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member

Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Treatment of Hypoparathyroidism at ENDO 2024

ENTX

GlobeNewswire

a year ago

Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Treatment of Hypoparathyroidism at ENDO 2024

Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates

ENTX

GlobeNewswire

a year ago

Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates

Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year?

ENTX

Zacks

a year ago

Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year?

ENTX

Zacks

a year ago

Entera Bio Ltd. (ENTX) Stock Slides as Market Rises: Facts to Know Before You Trade

ENTX

Zacks

a year ago

Why the Market Dipped But Entera Bio Ltd. (ENTX) Gained Today

ENTX

Zacks

a year ago

Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year?

ENTX

Zacks

a year ago

Here's Why You Should Invest in Entera Bio (ENTX) Stock Now

Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research

ENTX

GlobeNewswire

a year ago

Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research

Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint for Osteoporosis Drugs is Expected Within 10 Months

ENTX

GlobeNewswire

a year ago

Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint for Osteoporosis Drugs is Expected Within 10 Months

OPKO Health (OPK) And Entera Bio Announce Data for GLP-2

ENTX

Zacks

a year ago

OPKO Health (OPK) And Entera Bio Announce Data for GLP-2

12 Best Biotech Penny Stocks to Invest In

ENTX

Insider Monkey

a year ago

12 Best Biotech Penny Stocks to Invest In

ENTX

Simply Wall St.

a year ago

We Think Entera Bio (NASDAQ:ENTX) Can Afford To Drive Business Growth

Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome

ENTX

GlobeNewswire

a year ago

Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome

Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates

ENTX

GlobeNewswire

a year ago

Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates

Entera Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement

ENTX

GlobeNewswire

a year ago

Entera Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement

Spruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

ENTX

Business Wire

a year ago

Spruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Entera Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

ENTX

GlobeNewswire

a year ago

Entera Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Dow Jones Futures Loom As Microsoft, Apple Lead Earnings Tsunami

ENTX

Investor's Business Daily

a year ago

Dow Jones Futures Loom As Microsoft, Apple Lead Earnings Tsunami

Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010

ENTX

GlobeNewswire

a year ago

Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010

Broadwind (NASDAQ:BWEN) Shareholders Will Want The ROCE Trajectory To Continue

ENTX

Simply Wall St.

a year ago

Broadwind (NASDAQ:BWEN) Shareholders Will Want The ROCE Trajectory To Continue

Beneficient Closes Initial Series of Liquidity Transaction Financings of Limited Partner Interests Sourced Through Preferred Liquidity Provider Program (“PLP Program”)

ENTX

GlobeNewswire

a year ago

Beneficient Closes Initial Series of Liquidity Transaction Financings of Limited Partner Interests Sourced Through Preferred Liquidity Provider Program (“PLP Program”)

7 A-Rated Semiconductor Stocks to Buy in January

ENTX

InvestorPlace

a year ago

7 A-Rated Semiconductor Stocks to Buy in January

Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenue

ENTX

GlobeNewswire

a year ago

Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenue

Reasons to Add VirTra (VTSI) Stock to Your Portfolio Now

ENTX

Zacks

2 years ago

Reasons to Add VirTra (VTSI) Stock to Your Portfolio Now

Samsung Biologics selects Rapid Micro Biosystems’ Growth Direct® platform to automate critical microbiology quality control testing

ENTX

GlobeNewswire

2 years ago

Samsung Biologics selects Rapid Micro Biosystems’ Growth Direct® platform to automate critical microbiology quality control testing

Is Now The Time To Look At Buying Tuniu Corporation (NASDAQ:TOUR)?

ENTX

Simply Wall St.

2 years ago

Is Now The Time To Look At Buying Tuniu Corporation (NASDAQ:TOUR)?

Entera Bio Receives Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule

ENTX

GlobeNewswire

2 years ago

Entera Bio Receives Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule

$Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia$

ENTX

GlobeNewswire

2 years ago

Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia

Zevia to Participate in the 26th Annual ICR Conference

ENTX

Business Wire

2 years ago

Zevia to Participate in the 26th Annual ICR Conference

Entera Bio Announces Closing of Private Placement - Extends Cash Runway into 2025

ENTX

GlobeNewswire

2 years ago

Entera Bio Announces Closing of Private Placement - Extends Cash Runway into 2025

Outlook Therapeutics® Reports Financial Results for Fiscal Year 2023 and Reiterates ONS-5010 Clinical and Regulatory Path Forward in the U.S. and EU

ENTX

GlobeNewswire

2 years ago

Outlook Therapeutics® Reports Financial Results for Fiscal Year 2023 and Reiterates ONS-5010 Clinical and Regulatory Path Forward in the U.S. and EU

Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution

ENTX

PR Newswire

2 years ago

Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution

Annovis Bio Announces Last Patient Last Visit in the Phase III Study of Buntanetap in Parkinson’s Disease

ENTX

GlobeNewswire

2 years ago

Annovis Bio Announces Last Patient Last Visit in the Phase III Study of Buntanetap in Parkinson’s Disease

Tiziana Life Sciences to Present at the Webull LIVE! with Corporate Connect: Biotech Investment Webinar

ENTX

GlobeNewswire

2 years ago

Tiziana Life Sciences to Present at the Webull LIVE! with Corporate Connect: Biotech Investment Webinar

If You Can Only Buy One Quantum Computing Stock in December, It Better Be One of These 3 Names

ENTX

InvestorPlace

2 years ago

If You Can Only Buy One Quantum Computing Stock in December, It Better Be One of These 3 Names

Is Now The Time To Put FONAR (NASDAQ:FONR) On Your Watchlist?

ENTX

Simply Wall St.

2 years ago

Is Now The Time To Put FONAR (NASDAQ:FONR) On Your Watchlist?

ENTX

GlobeNewswire

2 years ago

Interim Results from Ongoing Clinical Study Confirm EB613 Optimized Profile for Osteoporosis Treatment and Potential for Entera’s Next Generation Oral Peptide Platform

Cutera, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 10-Q

ENTX

Business Wire

2 years ago

Cutera, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 10-Q

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q3 2023 Earnings Call Transcript

ENTX

Insider Monkey

2 years ago

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q3 2023 Earnings Call Transcript

Need To Know: The Consensus Just Cut Its Expensify, Inc. (NASDAQ:EXFY) Estimates For 2024

ENTX

Simply Wall St.

2 years ago

Need To Know: The Consensus Just Cut Its Expensify, Inc. (NASDAQ:EXFY) Estimates For 2024

ENTX

GuruFocus.com

2 years ago

Better Home & Finance Holding Co (BETR) Faces Market Headwinds in Q3 2023 Earnings

Strawberry Fields REIT Inc. Q4 2023 Cash Dividend of $0.12 per Common Share

ENTX

ACCESSWIRE

2 years ago

Strawberry Fields REIT Inc. Q4 2023 Cash Dividend of $0.12 per Common Share

Entera Bio Reports Q3 2023 Financial Results, Highlights Transformational Steps and Unveils Vision as Premier Oral Peptide Company with Five Potential Programs in Development

ENTX

GlobeNewswire

2 years ago

Entera Bio Reports Q3 2023 Financial Results, Highlights Transformational Steps and Unveils Vision as Premier Oral Peptide Company with Five Potential Programs in Development

Better Home & Finance Holding Company Announces Third Quarter 2023 Results

ENTX

Business Wire

2 years ago

Better Home & Finance Holding Company Announces Third Quarter 2023 Results

Allot to Release Third Quarter 2023 Earnings on November 16, 2023 and Reschedules Conference Call to November 22, 2023

ENTX

GlobeNewswire

2 years ago

Allot to Release Third Quarter 2023 Earnings on November 16, 2023 and Reschedules Conference Call to November 22, 2023

Unifi, Inc. (NYSE:UFI) is definitely on the radar of institutional investors who own 50% of the company

ENTX

Simply Wall St.

2 years ago

Unifi, Inc. (NYSE:UFI) is definitely on the radar of institutional investors who own 50% of the company

ENTX

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Aemetis Inc Earnings Call

Entera Bio Reports Key Milestone Relating to Oral PTH (1-34) Peptide (EB613) Phase 3 Program: ASBMR-SABRE Has Submitted to FDA the Full Qualification Plan to Approve BMD as a Surrogate Endpoint for Osteoporosis

ENTX

GlobeNewswire

2 years ago

Entera Bio Reports Key Milestone Relating to Oral PTH (1-34) Peptide (EB613) Phase 3 Program: ASBMR-SABRE Has Submitted to FDA the Full Qualification Plan to Approve BMD as a Surrogate Endpoint for Osteoporosis

Aemetis Inc (AMTX) Reports Mixed Q3 2023 Results with Strong Net Income Amidst Revenue Decline

ENTX

GuruFocus.com

2 years ago

Aemetis Inc (AMTX) Reports Mixed Q3 2023 Results with Strong Net Income Amidst Revenue Decline

ENTX

Associated Press Finance

2 years ago

Aemetis: Q3 Earnings Snapshot

Energy Recovery, Inc. (NASDAQ:ERII) Q3 2023 Earnings Call Transcript

ENTX

Insider Monkey

2 years ago

Energy Recovery, Inc. (NASDAQ:ERII) Q3 2023 Earnings Call Transcript

Better Launches Better Insurance to Provide Online Insurance Experience for American Homeowners

ENTX

Business Wire

2 years ago

Better Launches Better Insurance to Provide Online Insurance Experience for American Homeowners

Should You Invest in Seneca Foods Corporation (SENEA)?

ENTX

Insider Monkey

2 years ago

Latest Entera Bio Ltd. (ENTX) News on July 6, 2025

Share on Social Networks: